Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Livingstone

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Current Oncology Reports|April 2, 2023
The Latest Option: Nivolumab and Relatlimab in Advanced MelanomaLea Jessica Albrecht, Elisabeth Livingstone, Lisa Zimmer, et al.
Experimental Dermatology|April 14, 2015
Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanomaElisabeth Livingstone, Suzanne Swann, Carmen Lilla, et al.
Der Pathologe|March 25, 2020
[Malignant melanoma]Georg Lodde, Lisa Zimmer, Elisabeth Livingstone, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 28, 2019
[Malignant melanoma]Georg Lodde, Lisa Zimmer, Elisabeth Livingstone, et al.
Journal of Psychosocial Oncology|October 16, 2018
Predictors of quality of life in melanoma patients 4 years after diagnosis: Results of a nationwide cohort study in GermanyChristin Krajewski, Sven Benson, Sigrid Elsenbruch, et al.
Journal of Medical Internet Research|April 4, 2025
Psychological Factors Influencing Appropriate Reliance on AI-enabled Clinical Decision Support Systems: Experimental Web-Based Study Among DermatologistsAlisa Küper, Georg Christian Lodde, Elisabeth Livingstone, et al.
Studies in Health Technology and Informatics|September 8, 2022
Guideline-Based Context-Sensitive Decision Modeling for Melanoma PatientsCatharina Lena Beckmann, Georg Lodde, Elisabeth Livingstone, et al.
The Journal of Dermatology|June 28, 2016
Melanoma diagnosed in lesions previously treated by laser therapySarah Delker, Elisabeth Livingstone, Tobias Schimming, et al.
Journal of Clinical Medicine|June 19, 2024
Use of Real-World FHIR Data Combined with Context-Sensitive Decision Modeling to Guide Sentinel Biopsy in MelanomaCatharina Lena Beckmann, Georg Lodde, Jessica Swoboda, et al.
Sensors (Basel, Switzerland)|July 27, 2022
Validating Automatic Concept-Based Explanations for AI-Based Digital HistopathologyDaniel Sauter, Georg Lodde, Felix Nensa, et al.
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Current Oncology Reports|April 2, 2023
The Latest Option: Nivolumab and Relatlimab in Advanced MelanomaLea Jessica Albrecht, Elisabeth Livingstone, Lisa Zimmer, et al.
Experimental Dermatology|April 14, 2015
Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanomaElisabeth Livingstone, Suzanne Swann, Carmen Lilla, et al.
Der Pathologe|March 25, 2020
[Malignant melanoma]Georg Lodde, Lisa Zimmer, Elisabeth Livingstone, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 28, 2019
[Malignant melanoma]Georg Lodde, Lisa Zimmer, Elisabeth Livingstone, et al.
Journal of Psychosocial Oncology|October 16, 2018
Predictors of quality of life in melanoma patients 4 years after diagnosis: Results of a nationwide cohort study in GermanyChristin Krajewski, Sven Benson, Sigrid Elsenbruch, et al.
Journal of Medical Internet Research|April 4, 2025
Psychological Factors Influencing Appropriate Reliance on AI-enabled Clinical Decision Support Systems: Experimental Web-Based Study Among DermatologistsAlisa Küper, Georg Christian Lodde, Elisabeth Livingstone, et al.
Studies in Health Technology and Informatics|September 8, 2022
Guideline-Based Context-Sensitive Decision Modeling for Melanoma PatientsCatharina Lena Beckmann, Georg Lodde, Elisabeth Livingstone, et al.
The Journal of Dermatology|June 28, 2016
Melanoma diagnosed in lesions previously treated by laser therapySarah Delker, Elisabeth Livingstone, Tobias Schimming, et al.
Journal of Clinical Medicine|June 19, 2024
Use of Real-World FHIR Data Combined with Context-Sensitive Decision Modeling to Guide Sentinel Biopsy in MelanomaCatharina Lena Beckmann, Georg Lodde, Jessica Swoboda, et al.
Sensors (Basel, Switzerland)|July 27, 2022
Validating Automatic Concept-Based Explanations for AI-Based Digital HistopathologyDaniel Sauter, Georg Lodde, Felix Nensa, et al.
Pageof 19